{"filing":{"accession":"0001231589-26-000018","url":"/filing/0001231589-26-000018","form_type":"4","issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_name_source":null,"issuer_ticker":"UTHR","issuer_url":"/issuer/0001082554","period_of_report":"2026-08-20","filed_date":"2026-08-21","acceptance_dt":"2026-08-21T16:43:08+00:00","acceptance_label":"2026-08-21 16:43 UTC","ingested_at":"2026-08-22T05:23:40.159918+00:00","ingested_label":"2026-08-22 05:23 UTC","schema_version":null,"source":"Layline","parse_status":"parsed","parse_ok":true,"edgar_url":"https://www.sec.gov/Archives/edgar/data/1082554/0001231589-26-000018-index.htm","day_url":"/filings/2026-08-21"},"owners":[{"owner_cik":"0001231589","owner_name":"MAHON PAUL A","url":"/insider/0001231589","anchor":"owner-0001231589","role":"Officer (EVP & GENERAL COUNSEL)","officer_title":"EVP & GENERAL COUNSEL","is_director":false,"is_officer":true,"is_ten_percent":false,"is_other":false,"filing_anchor":"/filing/0001231589-26-000018#owner-0001231589"}],"line_owners":[{"owner_name":"MAHON PAUL A","role":"Officer (EVP & GENERAL COUNSEL)"}],"transactions":[{"id":9300356,"accession":"0001231589-26-000018","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001231589-26-000018","line_url":"/filing/0001231589-26-000018#line-1","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001231589","owner_name":"MAHON PAUL A","owner_display_name":"MAHON PAUL A","owner_url":"/insider/0001231589","role":"Officer (EVP & GENERAL COUNSEL)","role_mark":"O","role_mark_label":"Officer (EVP & GENERAL COUNSEL)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & GENERAL COUNSEL","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2690.0,"shares_display":"2,690","price_per_share":524.15,"price_display":"524.15","price_state":"stated","total_value":1409963.5,"total_display":"1,409,963.50","total_whole":"1,409,964","shares_owned_after":50782.0,"shares_owned_after_display":"50,782","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-20","filed_date":"2026-08-21","scope":"global","indirect_nature":null,"deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9300355,"accession":"0001231589-26-000018","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001231589-26-000018","line_url":"/filing/0001231589-26-000018#line-2","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001231589","owner_name":"MAHON PAUL A","owner_display_name":"MAHON PAUL A","owner_url":"/insider/0001231589","role":"Officer (EVP & GENERAL COUNSEL)","role_mark":"O","role_mark_label":"Officer (EVP & GENERAL COUNSEL)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & GENERAL COUNSEL","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":502.0,"shares_display":"502","price_per_share":520.0331,"price_display":"520.03","price_state":"stated","total_value":261056.6162,"total_display":"261,056.62","total_whole":"261,057","shares_owned_after":50280.0,"shares_owned_after_display":"50,280","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-20","filed_date":"2026-08-21","scope":"global","indirect_nature":null,"deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9300354,"accession":"0001231589-26-000018","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001231589-26-000018","line_url":"/filing/0001231589-26-000018#line-3","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001231589","owner_name":"MAHON PAUL A","owner_display_name":"MAHON PAUL A","owner_url":"/insider/0001231589","role":"Officer (EVP & GENERAL COUNSEL)","role_mark":"O","role_mark_label":"Officer (EVP & GENERAL COUNSEL)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & GENERAL COUNSEL","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1819.0,"shares_display":"1,819","price_per_share":521.0406,"price_display":"521.04","price_state":"stated","total_value":947772.8514,"total_display":"947,772.85","total_whole":"947,773","shares_owned_after":48461.0,"shares_owned_after_display":"48,461","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-20","filed_date":"2026-08-21","scope":"global","indirect_nature":null,"deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9300353,"accession":"0001231589-26-000018","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001231589-26-000018","line_url":"/filing/0001231589-26-000018#line-4","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001231589","owner_name":"MAHON PAUL A","owner_display_name":"MAHON PAUL A","owner_url":"/insider/0001231589","role":"Officer (EVP & GENERAL COUNSEL)","role_mark":"O","role_mark_label":"Officer (EVP & GENERAL COUNSEL)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & GENERAL COUNSEL","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":787.0,"shares_display":"787","price_per_share":522.0036,"price_display":"522.00","price_state":"stated","total_value":410816.8332,"total_display":"410,816.83","total_whole":"410,817","shares_owned_after":47674.0,"shares_owned_after_display":"47,674","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-20","filed_date":"2026-08-21","scope":"global","indirect_nature":null,"deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9300352,"accession":"0001231589-26-000018","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001231589-26-000018","line_url":"/filing/0001231589-26-000018#line-5","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001231589","owner_name":"MAHON PAUL A","owner_display_name":"MAHON PAUL A","owner_url":"/insider/0001231589","role":"Officer (EVP & GENERAL COUNSEL)","role_mark":"O","role_mark_label":"Officer (EVP & GENERAL COUNSEL)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & GENERAL COUNSEL","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":850.0,"shares_display":"850","price_per_share":522.7838,"price_display":"522.78","price_state":"stated","total_value":444366.23,"total_display":"444,366.23","total_whole":"444,366","shares_owned_after":46824.0,"shares_owned_after_display":"46,824","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-20","filed_date":"2026-08-21","scope":"global","indirect_nature":null,"deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9300351,"accession":"0001231589-26-000018","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001231589-26-000018","line_url":"/filing/0001231589-26-000018#line-6","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001231589","owner_name":"MAHON PAUL A","owner_display_name":"MAHON PAUL A","owner_url":"/insider/0001231589","role":"Officer (EVP & GENERAL COUNSEL)","role_mark":"O","role_mark_label":"Officer (EVP & GENERAL COUNSEL)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & GENERAL COUNSEL","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":192.0,"shares_display":"192","price_per_share":523.6897,"price_display":"523.69","price_state":"stated","total_value":100548.4224,"total_display":"100,548.42","total_whole":"100,548","shares_owned_after":46632.0,"shares_owned_after_display":"46,632","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-20","filed_date":"2026-08-21","scope":"global","indirect_nature":null,"deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9300350,"accession":"0001231589-26-000018","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001231589-26-000018","line_url":"/filing/0001231589-26-000018#line-7","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001231589","owner_name":"MAHON PAUL A","owner_display_name":"MAHON PAUL A","owner_url":"/insider/0001231589","role":"Officer (EVP & GENERAL COUNSEL)","role_mark":"O","role_mark_label":"Officer (EVP & GENERAL COUNSEL)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & GENERAL COUNSEL","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":940.0,"shares_display":"940","price_per_share":525.2504,"price_display":"525.25","price_state":"stated","total_value":493735.376,"total_display":"493,735.38","total_whole":"493,735","shares_owned_after":45692.0,"shares_owned_after_display":"45,692","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-20","filed_date":"2026-08-21","scope":"global","indirect_nature":null,"deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9300349,"accession":"0001231589-26-000018","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001231589-26-000018","line_url":"/filing/0001231589-26-000018#line-8","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001231589","owner_name":"MAHON PAUL A","owner_display_name":"MAHON PAUL A","owner_url":"/insider/0001231589","role":"Officer (EVP & GENERAL COUNSEL)","role_mark":"O","role_mark_label":"Officer (EVP & GENERAL COUNSEL)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & GENERAL COUNSEL","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":526.385,"price_display":"526.38","price_state":"stated","total_value":210554.0,"total_display":"210,554.00","total_whole":"210,554","shares_owned_after":45292.0,"shares_owned_after_display":"45,292","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-20","filed_date":"2026-08-21","scope":"global","indirect_nature":null,"deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9300348,"accession":"0001231589-26-000018","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001231589-26-000018","line_url":"/filing/0001231589-26-000018#line-9","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001231589","owner_name":"MAHON PAUL A","owner_display_name":"MAHON PAUL A","owner_url":"/insider/0001231589","role":"Officer (EVP & GENERAL COUNSEL)","role_mark":"O","role_mark_label":"Officer (EVP & GENERAL COUNSEL)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & GENERAL COUNSEL","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":120.0,"shares_display":"120","price_per_share":527.21,"price_display":"527.21","price_state":"stated","total_value":63265.2,"total_display":"63,265.20","total_whole":"63,265","shares_owned_after":45172.0,"shares_owned_after_display":"45,172","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-20","filed_date":"2026-08-21","scope":"global","indirect_nature":null,"deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null}],"n_transactions":9,"line_constants":{"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true},"provenance":{"source_pass":"Layline","parse_status":"parsed","schema_version":null,"retrieved_at":"2026-08-22T05:23:40.159918+00:00","retrieved_label":"2026-08-22 05:23 UTC","primary_document":"https://www.sec.gov/Archives/edgar/data/1082554/0001231589-26-000018-index.htm","accepted_at":"2026-08-21T16:43:08+00:00","accepted_label":"2026-08-21 16:43 UTC"},"related":[{"accession":"0001106578-26-000125","url":"/filing/0001106578-26-000125","form_type":"4","issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_name_source":null,"issuer_ticker":"UTHR","issuer_url":"/issuer/0001082554","period_of_report":"2026-08-20","filed_date":"2026-08-21","acceptance_dt":"2026-08-21T16:44:01+00:00","acceptance_label":"2026-08-21 16:44 UTC","ingested_at":"2026-08-22T05:23:40.159918+00:00","ingested_label":"2026-08-22 05:23 UTC","schema_version":null,"source":"Layline","parse_status":"parsed","parse_ok":true,"edgar_url":"https://www.sec.gov/Archives/edgar/data/1082554/0001106578-26-000125-index.htm","day_url":"/filings/2026-08-21"}],"related_rule":"Other filings held for the same issuer and the same period of report. This is a heuristic match, not an authoritative amendment link: the store holds no 4/A-to-original relation and the catalog does not invent one.","canonical_url":"https://ebomi.com/filing/0001231589-26-000018","retrieved_at":"2026-08-27T01:01:25+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}